Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1501-1505

  Martoni, Andrea Angelo ^a   Di Fabio, Francesca ^a   Melotti, Barbara ^a   Giaquinta, Stefania ^a   Guaraldi, Monica ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Gemcitabine; Non small cell lung cancer; Vinorelbine

Indexed keywords

AMINOTRANSFERASE; GEMCITABINE; NAVELBINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADVANCED CANCER; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ELDERLY CARE; ERYTHEMA; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL EDEMA; PRIORITY JOURNAL; RECURRENT CANCER; THROMBOCYTOPENIA; TREATMENT PLANNING; TREATMENT RESPONSE; VOMITING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; VINBLASTINE;

EID: 33645832218     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guidelines. Update 2003. J Clin Oncol 22: 330-353, 2003.
2. Gridelli C, Aapro M, Ardizzoni A et al: Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol 23: 3125-3137, 2005.
3. Gridelli C, Perrone F, Gallo C et al: Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 95: 362-372, 2003.
4. Edelman MJ and Gandara DR: Sequential chemotherapy: rationale and clinical trial design in advanced non-small-cell carcinoma. Clin Lung Cancer 1: 122-127, 1999.
5. Day R: Treatment sequencing, asymmetry and uncertainty: protocol strategies for combination chemotherapy. Cancer Res 46: 3876-3885, 1986.
6. Norton L and Simon R: The Norton-Simon hypothesis revisited. Cancer Treat Rep 70: 163-169, 1986.
7. Clark JI, Kancharla K, Quamar R et al: Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer. Lung Cancer 34: 271-277, 2001.
8. Guaraldi M, Marino A, Pannuti F, Farabegoli G and Martoni A: Phase II study of sequential treatment of advanced non-small-cell lung cancer: three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine. Clin Lung Cancer 3: 43-46, 2001.
9. Edelman MJ, Gandara DR, Lau DH et al: Sequential combination chemotherapy in patients with advanced non-small cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel. Cancer 92: 146-152, 2001.
10. Feliu J, Martin G, Lizon J et al: Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study. Ann Oncol 12: 1369-1374, 2001.
11. Grossi F, Belvedere O, Fasola G et al: Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001). Lung Cancer 46: 99-106, 2004.
12. Dongiovanni D, Fissore C, Berruti A et al: Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study. Lung Cancer 47: 269-275, 2005.
13. Hirsh V, Letreille J, Kreisman H et al: Sequential therapy with vinorelbine followed by gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities: a multicenter phase II trial. Lung Cancer 49: 117-123, 2005.
14. Martoni A, Di Fabio F, Guaraldi M et al: Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage HIB/IV non-small-cell lung cancer. Am J Clin Oncol 24: 614-617, 2001.
15. Miller AB, Hoogstraten B, Staquet M et al: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
16. Bonadonna G: Evolving concepts in the systemic adjuvant treatment of breast cancer. Cancer Res 52: 2127-2137, 1992.
17. Edelman MJ, Clark JI, Chansky K et al: Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel. Clin Cancer Res 10: 5022-5026, 2004.